FDA Nod For Novartis Drug To Avert Organ Failure In Liver Transplant RTT News Swiss drug maker Novartis AG (NVS: Quote), said Friday the U.S. Food and Drug Administration has approved Zortress as the first immunosuppressant in a decade to prevent organ rejection in adult liver transplant patients. The approval also means that ... |
